TLK2 and cancer: The degradation of oncoproteins like E2F, a transcription factor that regulates the expression of genes in cell proliferation, TLK2 (tousled-like kinase 2), cell cycle arrest, and apoptosis in cancer is promoted by the increased expression or activity components of the circadian clock (CLOCK, BMAL1) [71,143].